Biotech stock Prometheus Biosciences opened 70% up today: here’s why
Prometheus Biosciences Inc (NASDAQ: RXDX) opened about 70% up on Monday after Merck & Co Inc (NYSE: MRK) said it will buy the biotechnology company for $10.8 billion. What’s in it for Merck & Co? The all-cash agreement values each share of Prometheus Biosciences at $200 – over a 75% premium on the price at […]